Bluejay Investor Presentation Deck

Board of Directors Douglas C. Wurth, Chairman Indranil "Neil" Dey, CEO Svetlana Dey Donald R. Chase Fred S. Zeidman Gary Gemignani ●●● J.P. Morgan DIAGNOSTICS Skadden 20-year career at J.P. Morgan Chase (CEO of the International Private Bank & Alternative Investments, Asset Management) B.A Notre Dame University; J.D. University of Virginia School of Law; practiced law at Skadden, Arps, Meagher and Flom Involved in introducing Her2neu test for Herceptin and introduction of Erbitux Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary; MBA (Fulbright Scholar) from Cambridge University, UK Co-founder of Bluejay; President & CEO of LMBRI LLC; 15 years+ of management experience in healthcare industry Masters Degree in Mathematics from the State University of Mari El Republic, Russia 35 years in executive roles at well-known community banks in New England B.S. Accounting, Western New England University 50+ years of corporate advisory experience; Chairman Emeritus University of Texas Health Science System Bachelor's degree from Washington University in St. Louis; Masters in Business Administration from New York University Senior executive with experience in life sciences, public companies, accounting/finance Prior experience with Acacia Pharma, Biodel, Prudential Financial, Gentium, Novartis, Wyeth and Arthur Andersen IMPATH The Canon Com Imbri merchants BANCSHARES INC westbank UNITED STATES MEMORIAL LOCAUST MUSEUM ARTHUR ANDERSEN Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | November 2023 17

View entire presentation